Cervical adenomyoma is a rare benign growth made of gland and muscle tissue in the cervix. People with cervical adenomyoma may notice pelvic pain, heavy or irregular bleeding, and painful periods, while some have no symptoms. It tends to persist over time but does not turn into cancer, and the outlook is generally good. Cervical adenomyoma is usually found in adults, often during evaluation for bleeding or during a routine exam. Treatment often involves medications to control bleeding and pain, and many choose surgical removal of the lesion or hysterectomy depending on age, fertility goals, and symptom severity.
Overview
Cervical adenomyomaSymptoms
Cervical adenomyoma may cause irregular vaginal bleeding or spotting, especially after sex, and a watery or mucus-like discharge. Some feel pelvic pressure or cramping. Many have no symptoms and the growth is found during a pelvic exam.
Outlook and prognosis
Most cervical adenomyomas are benign and grow slowly. After complete removal, many people do well long term, with low risk of coming back; follow-up visits and imaging help catch rare recurrences. Fertility-sparing surgery is often possible if desired.
Causes and risk factors
Cervical adenomyoma’s cause isn’t well understood. It appears hormone-responsive, with estrogen exposure and perimenopausal or reproductive age increasing likelihood; pregnancy history may contribute. No clear genetic or lifestyle risks are established, and it’s not linked to HPV.
Genetic influences
Genetics currently appears to play a limited role in cervical adenomyoma. Most cases seem sporadic, with no clear inherited pattern or known high‑risk gene. Rare familial clustering is reported, but routine genetic testing isn’t recommended for cervical adenomyoma today.
Diagnosis
Cervical adenomyoma is usually suspected after a pelvic exam and imaging, such as transvaginal ultrasound or MRI. The diagnosis of cervical adenomyoma is confirmed by tissue analysis from biopsy or surgical removal to exclude cancer.
Treatment and drugs
Treatment for cervical adenomyoma focuses on easing bleeding and pelvic pain while preserving fertility when possible. Options may include hormonal therapy, minimally invasive removal (hysteroscopic or laparoscopic), or, if symptoms persist and childbearing is complete, hysterectomy. Care is individualized with gynecologic follow-up.
Symptoms
Many people notice unexpected vaginal bleeding or a watery discharge that doesn’t match their usual cycle. Symptoms vary from person to person and can change over time. Early symptoms of cervical adenomyoma can be subtle, like occasional spotting or light bleeding after sex. Some have no symptoms at all, and the growth is found during a routine pelvic exam or screening.
Light bleeding or pink/brown staining can show up between periods. You may see it on underwear or when wiping after using the toilet. It may come and go over weeks.
Small amounts of bleeding may occur after intercourse or a pelvic exam. With cervical adenomyoma, the surface of the cervix can be more fragile and prone to spotting.
Periods can be heavier or last longer than usual, sometimes with clots. You may need to change pads or tampons more often than is typical. This pattern can happen with cervical adenomyoma.
Thin, watery, or mucus-like discharge may increase, sometimes with a pink or brown tinge. It usually has little to no odor. This can be a sign of cervical adenomyoma.
How people usually first notice Cervical adenomyoma?
Many people first notice cervical adenomyoma because of abnormal vaginal bleeding—such as spotting between periods, heavier or longer periods, or bleeding after sex—or new pelvic cramping that doesn’t match their usual cycle. Some are told about it after a routine pelvic exam or ultrasound finds a small mass or polyp-like growth in the cervix, and it’s confirmed only after a biopsy shows a benign mix of gland and muscle. In others, it’s picked up during evaluation for infertility or recurrent pregnancy loss, so the “first signs of cervical adenomyoma” may be subtle and discovered during workups rather than through symptoms.
Types of Cervical adenomyoma
Cervical adenomyoma is uncommon, and doctors recognize a few well-described variants based on how the gland tissue and smooth muscle are arranged. These variants can look and feel similar, but they differ in where they sit in the cervix, how much they bleed, and what they resemble under the microscope. People may notice different sets of symptoms depending on their situation. When reading about types of cervical adenomyoma, you’ll see that spotting between periods, heavier periods, or postcoital bleeding may vary by variant, while pelvic exams and imaging help sort them out.
Typical adenomyoma
This classic form sits within the cervix and mixes gland tissue with smooth muscle. Many living with cervical adenomyoma notice spotting, heavier periods, or bleeding after sex. Imaging can suggest the diagnosis, but a biopsy confirms it.
Endocervical-type tumor
This variant is centered in the inner cervical canal with glands that resemble normal endocervical tissue. People with this type may have more mucus discharge along with bleeding. On exam, it can look like a polyp but is made of both glands and muscle.
Tunnel cluster variant
This form shows clusters of dilated glands that can mimic cysts in the cervix. Some may find intermittent spotting or a sensation of fullness low in the pelvis. Pathology distinguishes it from simple cysts by the muscle component.
Polypoid adenomyoma
This variant forms a polyp-like growth that may protrude from the cervix. For many, this can mean contact bleeding during intercourse or pelvic exams. It is usually removed because it bleeds and to rule out other conditions.
Minimal deviation-like
This rare type can resemble minimal deviation adenocarcinoma under the microscope. Symptoms can be subtle, with watery discharge or light bleeding over time. Careful pathology is needed to separate it from cancer.
Atypical/mitotically active
This uncommon variant shows more cell activity but still behaves in a benign way in most reports. People may notice more frequent bleeding or faster growth leading to pressure symptoms. Close follow-up after removal is often advised to monitor for recurrence.
What genetics can tell you about symptoms
Some cervical adenomyomas are linked to changes in genes that control hormone responses, which can drive heavier or irregular bleeding, cramping, and pressure symptoms. Variants in genes guiding tissue growth and repair may also relate to polyplike nodules and fertility or pregnancy difficulties.
Causes and risk factors
The exact cause of cervical adenomyoma is uncertain, but hormone-driven growth in the cervix appears to play a key role. Risk factors for cervical adenomyoma include higher lifetime estrogen exposure and being in the reproductive or perimenopausal years. Factors that raise estrogen, like pregnancy, obesity, or estrogen therapy, may influence risk, and prior childbirth or cervical procedures might contribute through local tissue changes. It is not known to be inherited, and there is no clear link to HPV or common sexually transmitted infections. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Environmental and biological risk factors
Cervical adenomyoma is a rare benign growth in the cervix that forms from glands and smooth muscle. Most known risks come from internal biology, especially hormones and age; clear outside triggers are not well defined. Researchers are still exploring how outside influences interact with our inner biology. If you’re reading because of early symptoms of cervical adenomyoma like light spotting or unexpected discharge, the points below summarize what is known about risk.
Shifts in estrogen and progesterone across the cycle or perimenopause can stimulate gland and muscle cells in the cervix. This hormone responsiveness can encourage small benign nodules to form.
The condition is more often found in people in their 30s to 50s. Age-related changes in cervical tissue and hormone levels may increase susceptibility in this window.
During pregnancy, high estrogen and progesterone remodel cervical tissue and increase blood flow. For some, these changes coincide with discovering cervical adenomyoma, though pregnancy itself is not proven to cause it. Most pregnancies progress without this growth.
No specific external exposures have been reliably linked to this condition. Current studies have not identified particular chemicals, infections, or pollutants that raise risk.
Genetic risk factors
Genetic causes of cervical adenomyoma are not well defined, and most cases appear to arise without an inherited trigger. Risk is not destiny—it varies widely between individuals. Genetics cannot reliably predict the early symptoms of cervical adenomyoma, and today there is no single marker doctors use to spot higher inherited risk.
Mostly sporadic: Most cervical adenomyomas occur as one-off events with no family pattern. A family history is not known to raise genetic risk. Genetic testing is usually not indicated.
Somatic gene changes: Some cervical adenomyomas show acquired DNA changes in the gland cells, with KRAS alterations reported in related conditions. These are local tissue events, not inherited from parents. No single recurring mutation has been confirmed for cervical adenomyoma.
Endometriosis overlap: In people with endometriosis or uterine adenomyosis, similar pathways and somatic gene changes may be present. This overlap supports a local origin of cervical adenomyoma rather than a hereditary syndrome. Still, most with those conditions never develop a cervical adenomyoma.
Developmental origin: Some cases may reflect displaced Müllerian tissue set during embryonic development. This is considered congenital but not clearly tied to inherited genes. It does not signal increased genetic risk for relatives.
No known syndromes: Cervical adenomyoma has not been linked to hereditary cancer or tumor syndromes. A diagnosis alone does not warrant germline genetic testing. Testing may be considered only if other strong personal or family features are present.
Lifestyle risk factors
Cervical adenomyoma is rare, and direct evidence on how lifestyle influences it is limited. Still, factors that affect estrogen/progesterone balance, metabolic health, and cervical tissue healing may influence growth, bleeding, or pain from these benign lesions. Below are lifestyle risk factors for Cervical adenomyoma summarized with practical connections to symptoms and progression. This aims to show how lifestyle affects CONDITION without implying causation.
Higher body fat increases peripheral estrogen production, which may stimulate growth in hormonally responsive cervical lesions. Weight reduction can lower estrogen exposure and may lessen abnormal bleeding.
Regular moderate exercise improves insulin sensitivity and can lower circulating estrogen and inflammation. This may reduce the likelihood of lesion growth and help manage bleeding or pelvic discomfort.
Alcohol can raise circulating estrogen levels. Higher intake may encourage lesion persistence or heavier bleeding, while cutting back may help with symptom control.
Diets high in refined carbs and ultra-processed foods can worsen insulin resistance and estrogen exposure. A fiber-rich, plant-forward pattern may aid estrogen metabolism and reduce bleeding or cramping.
Risk prevention
For most people, there’s no proven way to prevent cervical adenomyoma. Prevention is about lowering risk, not eliminating it completely. The practical focus is early detection and avoiding triggers that can worsen bleeding or pain. Paying attention to early symptoms of cervical adenomyoma and keeping up with routine gynecologic care can help you get evaluated and treated sooner.
Annual pelvic exams help clinicians spot unusual cervical changes early. Screenings and check-ups are part of prevention too.
Seek care if you notice bleeding between periods, bleeding after sex, persistent watery discharge, or new pelvic pain. Quick evaluation can catch cervical adenomyoma earlier and limit complications.
Discuss birth control, hormone therapy, or fertility medicines with your clinician. Using the lowest effective dose and regular monitoring may help avoid hormone-driven symptom flares.
If you live with endometriosis or fibroids, keeping them well managed can reduce confusing symptoms. This can help your care team focus on or rule out cervical adenomyoma sooner.
Transmission
Cervical adenomyoma is not contagious. It does not spread through sex, kissing, coughing, or casual contact, and it isn’t a sexually transmitted infection. There is no genetic transmission of cervical adenomyoma—how cervical adenomyoma is inherited isn’t a concern—because it develops as a local, benign overgrowth of gland and muscle tissue in the cervix rather than something passed from parent to child. In short, you can’t “catch” cervical adenomyoma, and it doesn’t spread to others.
When to test your genes
Consider genetic testing if you have multiple family members with gynecologic cancers, unusually early-onset cervical or endometrial disease, or a personal history of rare tumors where inherited cancer syndromes (like Lynch syndrome) are possible. Testing can guide screening frequency, surgical planning, and medication choices. Discuss with a genetic counselor to choose the right panel and timing.
Diagnosis
People with cervical adenomyoma are often evaluated after noticing irregular bleeding, unusual discharge, or a polyp-like growth that keeps coming back. Doctors usually begin with a careful exam and simple imaging, then move to targeted procedures to see the cervix up close. Because symptoms overlap with other conditions, including precancer and cancer, the diagnosis of cervical adenomyoma often relies on removing a small piece of tissue to examine under a microscope. Understanding how cervical adenomyoma is diagnosed can help you know what each step is looking for and why it matters.
Your provider asks about bleeding patterns, discharge, pain, prior procedures, and medications. These details point to likely causes and guide which tests come next.
The cervix and vagina are examined for visible growths, tenderness, or bleeding. A smooth, polyp-like mass may be seen but looks similar to other benign or precancerous changes.
These screening tests help identify cervical cell changes and high-risk HPV types. Normal results do not rule out adenomyoma but can help exclude common causes of abnormal bleeding.
Sound waves create images of the cervix and uterus to look for polyps, fibroids, or cyst-like areas. Adenomyoma may appear as a well-defined, mixed solid-and-cystic area but is not specific on ultrasound.
Stages of Cervical adenomyoma
Cervical adenomyoma does not have defined progression stages. This is a benign, typically localized growth in the cervix, so care is guided by symptoms and exam findings rather than a staging system. Different tests may be suggested to help confirm the diagnosis, such as pelvic ultrasound or MRI, and the final answer usually comes from a biopsy or removal examined under a microscope. Early symptoms of cervical adenomyoma can include spotting after sex, heavier periods, or pelvic discomfort, and follow-up visits can help track any changes.
Outlook and prognosis
Looking at the long-term picture can be helpful. For most people with cervical adenomyoma, the outlook is good because this is a benign (noncancerous) tumor. Many cases are found when investigating heavy periods, pelvic pain, or spotting after sex, and symptoms often improve after treatment. Surgery to remove the growth usually solves the problem, and the chance of it turning into cancer is very low.
Some choose conservative surgery to preserve fertility, while others have a hysterectomy if symptoms are severe or keep coming back. Recurrence can happen, especially if the lesion isn’t fully removed, so follow-up exams and imaging are important in the first couple of years after treatment. Mortality from cervical adenomyoma itself is not expected; when care is timely and complete, life expectancy is the same as for people without this condition.
Many people ask, “What does this mean for my future?”, and the answer is that day-to-day life typically returns to normal once bleeding and pain are controlled. If you’re planning a pregnancy, discuss options with your gynecologist, as the type and location of the adenomyoma and the surgery used can influence the best timing to conceive. If you ever notice early symptoms of cervical adenomyoma again—such as new heavy bleeding or persistent pelvic discomfort—check in with your clinician so they can rule out regrowth or other causes. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Many living with cervical adenomyoma deal with spotting, discharge, or cramping that can come and go over months. Long-term effects vary widely and depend on the size, location, and whether treatment removes the whole growth. Early symptoms of cervical adenomyoma, like light spotting after sex or between periods, can become long-term if the growth isn’t treated. For most, the condition is benign and symptoms improve or resolve after removal, with serious complications uncommon.
Spotting between periods or after sex can persist if the growth remains. Over time, some notice heavier or longer periods.
Low pelvic pain or cramp-like discomfort may flare around menstruation. These symptoms often ease after complete removal.
Mucus-like or blood-tinged discharge can continue for months. This can be bothersome and affect comfort and intimacy.
Chronic blood loss can lower iron levels, causing fatigue, dizziness, or shortness of breath. Blood counts usually rebound once bleeding is controlled.
How is it to live with Cervical adenomyoma?
Living with cervical adenomyoma often means navigating uncertainty more than pain. Many have no symptoms and discover it during a routine exam or imaging, while others notice irregular bleeding, cramping, or discomfort during sex that can disrupt work, intimacy, and plans. Treatment—often a minor procedure—can bring relief, though follow-up visits and the worry about recurrence may weigh on you and those close to you. Partners and family may share the concern, but clear information, a plan for symptom management, and regular check-ins with your clinician usually restore a sense of control.
Treatment and drugs
Treatment for cervical adenomyoma focuses on easing symptoms like heavy bleeding or pain and removing the growth if needed. Options range from watchful waiting with regular check-ins, to medicines that lighten bleeding or cramps, to procedures that remove the polyp-like mass through the cervix. Doctors sometimes recommend a combination of lifestyle changes and drugs, especially if periods are heavy or anemia develops. If symptoms persist or the mass is large, surgery such as hysteroscopic removal is common; in rare, stubborn cases and when childbearing is complete, a hysterectomy may be considered. Ask your doctor about the best starting point for you, especially if you’re planning a pregnancy or have other gynecologic conditions.
Non-drug treatment
Bleeding after sex, watery discharge, or pelvic pressure can interrupt daily plans; these can be early symptoms of cervical adenomyoma. Non-drug treatments often lay the foundation for care, from careful monitoring to minor procedures that remove the growth while preserving fertility. Choices depend on your symptoms, the size and position of the growth, and whether you hope for future pregnancy. A team approach with gynecology and imaging helps match the least invasive option to your needs.
Regular exams and ultrasound or MRI can track a small, symptom-free growth. This approach helps avoid procedures when cervical adenomyoma is stable. Ask your doctor which non-drug options might be most effective for your situation.
Simple removal of the cervical growth in the clinic can stop bleeding and discharge. It often takes only minutes and provides tissue to confirm the benign diagnosis. Many people with cervical adenomyoma feel relief quickly.
A thin scope passed through the cervix lets the surgeon shave or remove the growth under direct view. This uterus-sparing option can help if preserving fertility is a priority. Recovery is usually quick with light activity the next day.
For deeper or recurring growths, minimally invasive vaginal or laparoscopic surgery can remove the mass. This can ease pain and bleeding when office treatments are not enough. Not every approach works the same way, so plans are tailored.
Your genes may have an impact on how drugs work for you
Medications used around cervical adenomyoma—like pain relievers, hormonal therapies, or anesthesia—can work differently because gene variants affect drug breakdown, transport, and targets. Pharmacogenetic testing sometimes guides dose or drug choice to improve benefit and reduce side effects.
Pharmacological treatments
Cervical adenomyoma is usually treated with surgical removal, but medicines can help control symptoms or prepare for procedures. They may reduce heavy bleeding and cramping, and protect iron levels while you and your clinician evaluate early symptoms of cervical adenomyoma or plan surgery. Not everyone responds to the same medication in the same way. Choices depend on your goals, side effects, and whether you’re trying to conceive.
Over-the-counter ibuprofen or naproxen can ease cramps and reduce menstrual flow. They work best when started at the first sign of bleeding and taken with food. People with stomach ulcers, kidney disease, or certain heart risks should check with a clinician first.
This non-hormonal pill helps blood clot more effectively to reduce heavy bleeding on the days you take it. It’s used only during heavy flow days, not daily. It is not suitable for some people with a history of blood clots or certain eye conditions.
Estrogen–progestin pills, patches, or rings can regulate cycles and lighten bleeding. They may help with cramps and spotting between periods. They aren’t a fit for everyone, including some who smoke over age 35 or have migraine with aura or clotting risks.
Oral progestins (such as norethindrone or medroxyprogesterone), injections, or a levonorgestrel intrauterine system can thin the uterine lining and lessen bleeding. The IUD works mostly inside the uterus, which can limit whole‑body side effects and provides contraception. Some may notice irregular bleeding at first, which often settles over time.
Genetic influences
Genetic factors do not seem to play a major role in cervical adenomyoma. Most cases are sporadic, with no clear pattern in families and no single gene change known to raise risk. Genetics is only one piece of the puzzle, but hormones and local tissue growth signals appear to be more important drivers for cervical adenomyoma. Researchers have not identified an inherited gene change linked to cervical adenomyoma, and routine genetic testing is not recommended for diagnosis or management. Family clusters are uncommon, and a relative’s history of other gynecologic growths does not mean you’ll develop cervical adenomyoma or notice early symptoms of cervical adenomyoma. When genetic studies are done, they usually examine the tissue itself for changes that affect only that growth and do not translate into inherited risk.
Is Cervical adenomyoma genetic?
Genetics currently appears to play a limited role in cervical adenomyoma. Most cases seem sporadic, with no clear inherited pattern or known high‑risk gene. Rare familial clustering is reported, but routine genetic testing isn’t recommended for cervical adenomyoma today.
Pharmacogenetics—how genetics influence drug effects
Treatment for cervical adenomyoma is mainly surgical, and there aren’t gene‑targeted drugs for this benign growth, so tumor genetic testing isn’t usually part of care. Genetics can still shape the medicines used around treatment, especially pain relievers, anti‑inflammatory drugs, and, in some cases, hormones for bleeding. Genetic testing can sometimes identify how your body handles certain pain medicines, like codeine or tramadol, which helps avoid poor pain control or unexpected side effects. For common anti‑inflammatory painkillers, inherited differences in liver enzymes can raise drug levels, so your doctor may start with a lower dose or choose an alternative to reduce stomach, kidney, or bleeding risks. If hormones are used to regulate bleeding, genes that influence how estrogen and progestin are broken down can affect benefits and side effects; a personal or family history of blood clots is also important when considering estrogen‑containing options. During surgery for cervical adenomyoma, let your team know about any family history of malignant hyperthermia (a rare inherited reaction to anesthesia), as this guides the choice of safe anesthetic medicines.
Interactions with other conditions
Bleeding and cramping from cervical adenomyoma often overlap with other gynecologic conditions like endometriosis, adenomyosis, or uterine fibroids, so it can be hard to tell which one is driving symptoms on a given month. When these conditions occur together, heavy periods and pelvic pain may be more pronounced, and ongoing blood loss can increase the risk of iron‑deficiency anemia. Doctors call it a “comorbidity” when two conditions occur together. Cervical infections or inflammation can also make bleeding and discharge worse, and blood‑thinning medicines (such as warfarin or certain antiplatelets) may intensify bleeding linked to cervical adenomyoma.
There’s no clear evidence that cervical adenomyoma is caused by HPV, but because early symptoms of cervical adenomyoma can mimic cervical cancer, clinicians usually rule out cancer with careful exams and tissue testing. Hormone‑based treatments used for endometriosis or fibroids—like progestins or GnRH medicines—may also ease bleeding and pain from cervical adenomyoma, which is one reason coordinated care can be helpful. In pregnancy, most small cervical adenomyomas do not cause problems, but larger lesions or coexisting fibroids may raise the chance of bleeding or require tailored delivery planning. Interactions can look very different from person to person, so let your care team know about all diagnoses and medications to help fine‑tune management.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described heavy menstrual bleeding, pelvic pressure, and fertility struggles that today we recognize can sometimes be linked to growths arising in the cervix. Midwives and surgeons noted firm, polyp-like masses that bled easily when touched. Some people were told they had “polyps,” others “fibroids,” and a few were simply advised to live with the symptoms. Looking back, the condition has often been redefined as clinicians gained better tools to see and sample cervical tissue.
First described in the medical literature as a rare, benign mixture of gland tissue and smooth muscle, cervical adenomyoma was long overshadowed by more common cervical polyps and uterine fibroids. Early reports came from surgical specimens removed because of bleeding after sex, irregular bleeding between periods, or unexplained cramping. Without modern imaging, many lesions were discovered only during procedures like dilation and curettage or after childbirth, when unusual cervical tissue was noticed and sent to the lab.
As medical science evolved, clearer microscopes and standardized staining let pathologists distinguish cervical adenomyoma from look-alike conditions, including adenomyosis in the uterus and certain cervical cancers. This mattered, because the glands in adenomyoma can appear crowded, and in the past that sometimes led to worry about malignancy. Over time, descriptions became more precise, emphasizing its well-organized smooth muscle, benign gland patterns, and the way it stays confined to the cervix.
In recent decades, awareness has grown alongside better pelvic ultrasound and MRI. Imaging started to reveal well-defined cervical masses with mixed solid and cystic areas, prompting targeted biopsies instead of broad procedures. Colposcopy and improved office-based sampling also meant more people received a specific diagnosis before surgery, reducing overtreatment. Case series from different regions showed that cervical adenomyoma can affect adults across a wide age range, most often during reproductive years, and that many were found when investigating spotting, postcoital bleeding, or fertility concerns.
Medical classifications changed as international pathology groups refined criteria and separated benign gland-muscle lesions from precancer and cancer. That shift helped guide care toward conservative surgery—such as local excision or polypectomy—when appropriate, especially for those wishing to preserve fertility. It also underscored that, while uncommon, cervical adenomyoma is a distinct benign entity with its own pattern on exam, imaging, and under the microscope.
Today, the history of cervical adenomyoma reflects a broader arc in gynecology: moving from symptom-based labels to tissue-specific diagnoses. Knowing the condition’s history helps explain why older records might list different names for the same finding, and why a second look by a specialist pathologist can be reassuring. Continued reporting of cases and follow-up studies has strengthened confidence that, once properly diagnosed and removed when needed, outcomes are typically good.